NICE rule out breast cancer drug over cost
A drug that can extend the lives of some women with an advanced form of breast cancer has been rejected for use by National Health Service because it is too
Read MoreA drug that can extend the lives of some women with an advanced form of breast cancer has been rejected for use by National Health Service because it is too
Read MoreCancer patients who are lonely are three times more likely to struggle to follow their treatment plan than those who aren’t lonely, according to research by Macmillan Cancer Support. Using
Read MoreThe UK is set to become the world leader in ground-breaking genetic research into cancer and rare diseases, which will transform how diseases are diagnosed and treated, thanks to a
Read MoreFrom September 2014 a new module will be available from the Cancer Education Team at Edinburgh Napier University (ENU). The course ‘Supporting patients living with and beyond cancer’ was developed
Read MorePeople in the UK are grossly misinformed about breast cancer survival and fail to realise how poor it is compared with other countries, according to a leading charity. Only a
Read MoreA pilot project to test new ways of measuring cancer waiting times in Wales are underway, the Welsh Government has announced. A single cancer pathway will be piloted, measured and
Read MoreToo many cancer patients are being shown a “lack of compassion” by healthcare workers, a charity said. A fifth of cancer patients said they felt like a “set of symptoms”
Read MoreA “tipping point” has been reached in the war against cancer with half of newly diagnosed patients in England and Wales surviving at least 10 years, a landmark study has
Read MoreA new drug for breast cancer which extends women’s lives by almost six months is to be blocked from routine NHS access under draft guidance issued by a health watchdog.
Read MoreAdverts for a pancreatic cancer charity that featured sufferers saying they would rather have a different form of the disease have been cleared following 121 complaints. The three press ads
Read More